Nervgen Pharma NGEN
NASDAQ NGEN
$1.53 -0.01 (-0.65%)
As of: Oct 21, 2026 · 11:41 AM EDT

Nervgen Pharma (NGEN) Total Liabilities (2024 - 2026)

Updated

Nervgen Pharma's Total Liabilities came in at $52.71 million for the quarter ended Jun 30, 2026, up 374.8% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Total Liabilities (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma's Total Liabilities was $14.12 million, up 14.4% from the prior year.

  • Going back by year, Total Liabilities was $12.35 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 116.09 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 141.05 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 65.46 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 37.53 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 115.64 Bn
10 Nervgen Pharma 110.30 Mn 9.19 Mn - 51.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.32 Mn
Mar 31, 2026 10.93 Mn
Dec 31, 2025 14.41 Mn
Dec 31, 2024 11.78 Mn
API Access

Nervgen Pharma Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=NGEN&period=max&api_key=YOUR_API_KEY